Corporate News / Events :: Aethlon Medical, Inc. (AEMD)

Important Update

Statement regarding Aethlon’s position with respect to the potential for use of the Hemopurifier as a countermeasure against the current coronavirus SARS-CoV-2 (COVID-19) outbreak

Recent News

May 17, 2022

Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference

May 2, 2022

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

Upcoming Events

May 24, 2022 • 7:00am EDT

H.C. Wainwright Global Investment Conference

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up